Poland· PL-100330154

Gemcitabine SUN

A gemcitabine product containing gemcitabinum, registered in Poland by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01BC05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGemcitabine SUNATCL01BC05REGISTER NO.PL-100330154PACKS LISTED21CHECKEDSeptember 27, 2026

Where it is registered

Gemcitabine is registered in 17 of 19 countries.

Countries holding a registration under ATC L01BC05 (gemcitabine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Gemcitabine · ATC L01BC05

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gemcitabine costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Gemcitabine · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$27.60
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Gemcitabinum
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Country
Poland (PL)
ATC code
L01BC05
ATC class
Gemcitabine
Defined daily dose
0.2 g, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 21

  • gtin
    05909991285302
  • gtin
    05909991285319
  • gtin
    05909991285326
  • gtin
    05909991285333
  • gtin
    05909991285340
  • gtin
    05909991285357
  • gtin
    05909991285364
  • gtin
    05909991285371
  • gtin
    05909991285388
  • gtin
    05909991285395
  • gtin
    05909991285401
  • gtin
    05909991285418
  • gtin
    05909991285425
  • gtin
    05909991285432
  • gtin
    05909991285449
  • gtin
    05909991285456
  • gtin
    05909991285463
  • gtin
    05909991285470
  • gtin
    05909991390631
  • gtin
    05909991390648
  • gtin
    05909991390655

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

370 interactions on record for gemcitabine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gemcitabine · interactions on record

370 records

  • 33 severe
  • 114 moderate
  • 19 minor
  • 204 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CladribineL01BB04severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gemcitabine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gemcitabine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Gemcitabin Accord, Gemcitabin Ebewe
  • Belgium · Gemcitabin Sandoz, Gemcitabin Sun
  • Bulgaria · Гемсол, Гемцитабин Акорд
  • Cyprus · Gemcitabine Accord, Gemnil
  • Czechia · Gemcitabin Ebewe, Gemcitabin Sun
  • Germany · Bendacitabin, Gemci-Cell
  • Denmark · Gemcitabin "sandoz", Gemcitabin Accord
  • Estonia · Gemcitabine Accord, Gemcitabine Kabi
  • Spain · Gemcitabina Accord, Gemcitabina Aurovitas Spain
  • Finland · Gemcitabin Accord, Gemcitabin Sandoz
  • France · Gemcitabine Accord, Gemcitabine Arrow
  • United Kingdom (Northern Ireland) · Gemcitabine Accord Healthcare, Gemcitabine Ennogen Ip
  • Greece · Demozar, Gemcipen
  • Croatia · Gemcitabin Accord, Gemcitabin Sandoz
  • Hungary · Gemcitabin Kabi, Gemcitabine Accord
  • Ireland · Gemcitabine, Gemcitabine Accord Healthcare
  • Iceland · Gemcitabin Wh, Gemkabi
  • Italy · Gemcitabina Accord, Gemcitabina Aurobindo Pharma Italia
  • Lithuania · Gemcitabine Accord, Gemcitabine Kabi
  • Luxembourg · Gemcitabine Eg, Gemcitabine Eugia
  • Latvia · Gemcitabine Accord, Gemcitabine Kabi
  • Malta · Gemcitabine Pfizer Hellas, Gemnil
  • Netherlands · Gemcitabine Accord, Gemcitabine Fresenius Kabi
  • Norway · Gemcitabin Sandoz, Gemcitabin Sun
  • Portugal · Gemcit, Gemcitabina Accord
  • Romania · Gemcitabină Accord, Gemcitabina Kabi
  • Sweden · Gemcitabin Sandoz, Gemcitabin Sun
  • Slovenia · Gemcitabin Accord, Gemcitabin Kabi
  • Slovakia · Gemcitabín Sun, Gemcitabine Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/76b0abb3-4769-4fe7-a63f-c54482d17647
GET /v1/drugs/76b0abb3-4769-4fe7-a63f-c54482d17647?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do infuzji",
  "source": "urpl",
  "strength": "10 mg/ml",
  "packaging": "05909991285302 ¦ Lz ¦ 116792\n1 worek 170 ml\n05909991285319 ¦ Lz ¦ 116793\n1 worek 120 ml\n05909991285326 ¦ Lz ¦ 116794\n1 worek 220 ml\n05909991285333 ¦ Lz ¦ 116795\n1 worek 200 ml\n05909991285340 ¦ Lz ¦ 116796\n1 worek 160 ml\n05909991285357 ¦ Lz ¦ 116797\n1 worek 180 ml\n05909991285364 ¦ Lz ¦ 116798\n5 worków 220 ml\n05909991285371 ¦ Lz ¦ 116799\n5 worków 160 ml\n05909991285388 ¦ Lz ¦ 116800\n5 worków 180 ml\n05909991285395 ¦ Lz ¦ 116801\n5 worków 120 ml\n05909991285401 ¦ Lz ¦ 116802\n5 worków 170 ml\n05909991285418 ¦ Lz ¦ 116803\n5 worków 200 ml\n05909991285425 ¦ Lz ¦ 116804\n10 worków 180 ml\n05909991285432 ¦ Lz ¦ 116805\n10 worków 170 ml\n05909991285449 ¦ Lz ¦ 116806\n10 worków 120 ml\n05909991285456 ¦ Lz ¦ 116807\n10 worków 220 ml\n05909991285463 ¦ Lz ¦ 116808\n10 worków 200 ml\n05909991285470 ¦ Lz ¦ 116809\n10 worków 160 ml\n05909991390631 ¦ Lz ¦ 130681\n1 worek 140 ml\n05909991390648 ¦ Lz ¦ 130682\n5 worków 140 ml\n05909991390655 ¦ Lz ¦ 130683\n10 worków 140 ml",
  "substance": "Gemcitabini hydrochloridum 11,384 mg/ml",
  "common_name": "Gemcitabinum",
  "pl_product_id": "100330154",
  "pozwolenie_nr": "23323",
  "auth_procedure": "DCP",
  "authorisation_validity": "2024-03-26"
}

See everything about gemcitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.